Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
Condition: COVID-19 Intervention: Biological: Dental pulp mesenchymal stem cells Sponsor: CAR-T (Shanghai) Biotechnology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Coronavirus | COVID-19 | Pneumonia | Research | Stem Cell Therapy | Stem Cells